Intervention

mutant p53 peptide pulsed dendritic cell vaccine

ClinicalTrials.gov intervention label

Clinical trials2

Recruiting0

Common conditions6

Lead sponsors shown1

Clinical trials

2 shown

Vaccine Therapy in Treating Patients With Stage III Non-Small Cell Lung CancerNCT00019929 · 2000-08-01

Vaccine Therapy and Biological Therapy in Treating Patients With Advanced CancerNCT00019084 · 1996-02-01

Common conditions

Lung Cancer2 Breast Cancer1 Cervical Cancer1 Colorectal Cancer1 Ovarian Cancer1 Pancreatic Cancer1

Leading sponsors

National Cancer Institute (NCI)2

Trial status mix

COMPLETED2

Phase mix

PHASE22

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.